the standard errors applicable to each survival interval can be readily calculated. The calculation of survival rates, however, depends to a great extent on the number of patients considered, and the error of the predicted rate becomes unacceptable if the numbers are small. Clearly, a high survival rate is attainable in the treatment of renal failure by home dialysis. Most of the patients in the series have been treated by this method. The fact that transplantation has apparently not adversely affected the survival rate, despite the failure of several transplants, is due to dialysis therapy being restarted after transplant failure.
In computing survival when both dialysis and transplantation have been used in the same patient dialysis periods have been assumed to be continuous. This is because the response to treatment of a patient who rejects a transplant and is returned to dialysis is comparable with that obtained before transplantation, with the possible exception of patients who have serious side effects from treatment with steroids and immunosuppressive agents. No more than one change of treatment occurred in the transplant patients considered here. Apparently survival is unrelated to social status, since both surviving and deceased patients came from all walks of life.
No systematic reason for the improved survival of men over women was found, but possibly women are less well able to tolerate the stress of the treatment. Firm conclusions cannot be drawn at this point, however, since the number of deaths is small. No difference between the survival rates of men and women was found by Lewis et al. (1970) .
Though it is difficult to isolate factors contributing to survival, the role of medical, nursing, dietary, and organizational policies is clear. Technically superior performance in dialysis, dietary therapy, and the control of hypertension are of great importance. Similarly, it is essential that the patient assumes responsibility for dialysis and that direct links with advisers in the hospital are provided should a technical or medical problem arise. The patient definitely seems to appreciate and respond to efforts to restore him to his home and natural environment, particularly if this is done sympathetically but objectively.
The five-year overall survival rate of 80-7% for combined therapy in this programme is an improvement on the fiveyear survival rate of 578% reported by Lewis et al. (1969) 
Introduction
Some degree of folate deficiency occurs in almost all patients with untreated adult coeliac disease. The most likely explanation for this is malabsorption of dietary folate, since the disease predominantly affects the structure and function of the proximal small-intestinal mucosa, the principal site of folate absorption. Malabsorption of pteroylglutamic acid (folic acid) assayed microbiologically has been shown to occur in this disease by the demonstration of subnormal folate excretion (Girdwood, 1953) and subnormal rise in serum pteroylglutamic acid (Chanarin et al., 1958;  Klipstein, 1966) after oral doses of pteroylglutam-iic acid. Subnormal absorption of tritiated pteroylglutamic acid has also been shown by both urinary and faecal excretion techniques to occur in adult coeliac disease (Anderson et al., 1960; Kinnear et al., 1963; Kremenchuzky et al., 1967; Stewart et al., 1967) .
In a few patients with untreated adult coeliac disease, however, the results of tests of pteroylglutamic acid absorption are normal even though severe folate deficiency is present (Chanarin et al., 1958; Anderson et al., 1960; Stewart et al., 1967) . Moreover, occasional adult coeliac patients with megaloblastic anaemia show an excellent haematological response to pteroylglutamic acid when this is given by mouth in physiological (50-200 jig.) doses, an observation which also suggests that absorption of pteroylglutamic acid is not grossly impaired in these particular patients (Mollin and Waters, 1968) .
One possible explanation for this severe folate deficiency in the presence of normal absorption of pteroylglutamic acid is that in these patients absorption of food folate is more severely impaired than absorption of crystalline pteroylglutamic acid itself. Food folate consists largely of polyglutamate forms of folate in which the pteroyl portion of the molecule is linked to six, seven, or more glutamate moieties instead of to one glutamate moiety as in pteroylglutamic acid. These polyglutamate compounds are hydrolysed to pteroylmonoglutamate during absorption (Butterworth et al., 1969) , probably by the enzyme pteroylpolyglutamate hydrolase (formerly called "folate conjugase") within the jejunal mucosa.
The main purpose of the present study was to compare the absorption of pteroylpolyglutamates and pteroylglutamic acid in patients with untreated adult coeliac disease and to measure the pteroylpolyglutamate hydrolase content of the jejunal mucosa in these patients. Since some patients with dermatitis herpetiformis show jejunal mucosal abnormalities similar to those found in coeliac disease, and such patients may also show folate deficiency despite normal absorption of pteroylglutamic acid (Fry et al., 1967) , folate absorption tests and enzyme estimations were also performed in a group of folate-deficient patients with this skin disease.
Finally, the studies were performed in three patients diagnosed clinically as suffering from nutritional folate deficiency to exclude a defect in absorption of dietary folate as a factor in their deficiency state.
Patients Studied
Folate absorption tests were performed in the following patients:
(1) Ten Patients with Untreated Adult Coeliac Disease.-In each the diagnosis had been made on the demonstration of steatorrhoea and malabsorption of xylose, the grossly abnormal jejunal biopsy appearance, and the presence of folate deficiency (Table I) . At the time of the present folate absorption studies these patients had received no treatment other than saturating doses of folic acid (see later). Jejunal pterovlpolyglutamate hydrolase activity was measured in eight of these patients and in a further seven with the untreated disease. The enzyme activity was also measured in two adult coeliac patients who were in remission while taking a gluten-free diet. These two patients had normal serum folate levels at the time a jejunal biopsy was taken for enzyme assay.
(2) Five Patients with Dermatitis Herpetiformis.-Each of these patients had skin lesions typical of this disease, for which they were receiving dapsone therapy. In addition each patient had folate deficiency (Table I ). The jejunal biopsy of four showed a flat mucosa and "subtotal villous atrophy," and in one broad leafy villi were seen under the dissecting microscope, the histological appearances showing blunting of the villi and a pronounced cellular infiltrate.  Hoffbrand and Peters, 1969).
Other Methods. Haematological methods were standard (Dacie and Lewis, 1968) . Serum vitamin B12 levels were determined by microbiological assay with the "z" strain of Euglena gracilis (Anderson, 1964) . Normal levels range from 160 to 925 pg./ml. Red cell folate levels are measured by microbiological assay with L. casei after haemolysis of whole blood. The levels in normal subjects range from 160 to 640 ng./ml. packed red cells (Hoffbrand et al., 1966 ,, 
Folate Absorption Tests
Normal Subjects.-The absolute rise in serum folate in the 14 normal subjects following the oral dose of pteroylglutamic acid ranged from 7-5 to 22-0 ng./ml., with a mean of 115 ng./ml. (Table II) . The absolute rise in serum folate following an equivalent oral dose of pteroylpolyglutamates ranged from 7-0 to 18*0 ng./ml., with a mean of 10.3 ng./ml. There was no significant difference in the overall rise in serum folate following the two different forms of folate (t test for paired samples,P=0 1).
Patients with Untreated Adult Coeliac Disease.-All but two of these 10 patients showed subnormal rises in serum folate following the oral dose of pteroylglutamic acid (<7-5 ng./ml.), and in the remaining two (Cases 9 and 10, Table III) the rises were just normal (8.0 and 9.8 ng./ml. respectively). An absorptive defect for pteroylpolyglutamates was even more frequent among these patients, since all 10 showed subnormal rises in serum folate (<7-0 ng./ml.) following the oral dose of pteroylpolyglutamates. There was no statistically significant difference in the rise in serum folate following ingestion of the two forms of folate among these patients, however (t test for paired samples, P=0-24), though two patients (Cases 9 and 10) showed subnormal rises in serum folate after pteroylpolyglutamate ingestion and normal rises after pteroylglutamic acid.
Patients with Dermatitis Herpetiformis.-Only two of these five patients showed subnormal rises in serum folate after oral pteroylglutamic acid, whereas four of them showed subnormal rises after oral pteroylpolyglutamates (Table III) . The overall rise following pteroylpolyglutamates was significantly lower than that following pteroylglutamic acid (t test for paired samples, P=0-05). One patient showed normal rises in serum folate after both forms of folate (Case 15, Table  III ). Patients with Nutritional Folate Deficiency.-All three patients showed normal rises in serum folate after ingestions of both pteroylglutamic acid and pteroylpolyglutamates (Table III) (Jeejeebhoy et al., 1968; (Fordtran et al., 1967) .
Possibly also there is a defect of some enzyme concerned with folate absorption and this causes malabsorption of folate. One enzyme thought to be necessary for absorption of the polyglutamate forms of folate is pteroylpolyglutaamate hydrolase. This enzyme is localized to the lysosomes of the jejunal mucosal cells (Hoffbrand and Peters, 1969) , and on histological and histochemical evidence these subcellular organelles are damaged in coeliac disease (Riecken et al., 1966) . No times normal in coeliac disease (Croft et al., 1968) . The jejunal mucosal cells contain small but significant amounts of folate mainly in the polyglutamate form (Hoffbrand and Peters, 1969) . Failure of reabsorption of this folate as well as of that contained in bile (S. J. Baker et al., 1965) could well contribute to the development of folate deficiency in both coeliac disease and dermatitis herpetiformis.
Most workers consider that dietary folate deficiency occurs frequently in Western communities. This is consistent with the generally accepted concept of Herbert (1968) , that minimal daily requirements for folate (100 pg.) are not many times lower than normal daily dietary folate intake (500 to 1,000 pg.). A few workers, however, suggest that daily folate requirements are as little as 10,ug. (see Vitale, 1966) . If this were so it would be extremely difficult to develop the deficiency simply by taking a poor diet. It would therefore be necessary to postulate that some degree of malabsorption of dietary folate occurred in many patients diagnosed clinically as suffering from "pure" nutritional folate deficiency. The present results, however, show normal absorption of pteroylpolyglutamates and normal jejunal mucosal pteroylpolyglutamate hydrolase levels in three such patients and thus support the concept of inadequate dietary intake of the vitamin as the sole cause of their deficiency.
